H26.33
Drug-induced cataract, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Drug-induced cataracts are a type of cloudy lens formation in the eye caused by certain medications. When these cataracts affect both eyes, they are referred to as bilateral. This condition can develop over time with prolonged medication use and may impact vision. Recognizing the causes, symptoms, and treatment options can help manage this condition effectively.
Causes & Symptoms
Clinical Causes: Long-term use of corticosteroids, such as prednisone Certain antipsychotic medications Some medications used to treat glaucoma Specific drugs used in cancer therapy like chlorpromazine Chemotherapy agents that may induce cataract formation Exposure to certain drugs that impact lens metabolism
Key Symptoms: Gradual blurring of vision Difficulty seeing in low light conditions Sensitivity to glare and bright lights Colors appearing dull or faded Presence of cloudy or cloudy patches in the visual field Possible perception of a halo around lights
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves an eye examination by an ophthalmologist, who will assess the clarity of the lenses. Visual acuity tests may be performed to understand the extent of vision impairment. In some cases, imaging techniques like slit-lamp examination can detail the severity and pattern of lens clouding. Medical history is also reviewed to identify medication use that may contribute to cataract formation.
Treatment Protocols: The primary treatment for drug-induced bilateral cataracts is usually surgical removal of the affected lenses, particularly if vision loss impacts daily activities. Prior to surgery, the healthcare provider may evaluate whether discontinuing or switching medications is possible. Post-surgical recovery generally involves the use of corrective glasses or contact lenses to restore clear vision. Regular follow-up visits are essential to monitor healing and manage any potential complications.
Clinical Advice & FAQs
Billing Guidance
Is H26.33 a billable ICD-10 code?
Yes, H26.33 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H26.33?
Clinical documentation must specify the nature of Drug-induced cataract, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference